Delivery Order SPE2DE24D0013-SPE2D625F8AX2
- Not listed
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- The U.S. Defense Department's Medical Supply Chain division awarded a $23,475.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPCOV2/FLU/RSV-10, was awarded on July 29, 2025, with an ultimate completion date of August 12, 2025, and carries no set-aside designation. Work will be performed at Cepheid's Sunnyvale facility. This delivery order represents procurement of diagnostic testing...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Department of Defense Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This delivery order, issued on August 7, 2025, with an ultimate completion date of August 14, 2025, represents a continuation of Cepheid's established role as a primary supplier of advanced diagnostic systems and test kits to federal healthcare entities. The...
- The Defense Logistics Agency's Medical Supply Chain division awarded an $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer specializing in infectious disease testing solutions. This delivery order, issued on August 5, 2025, with an ultimate completion date of August 12, 2025, is designated as XPCOV2/FLU/RSV-10 and relates to diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV). The...
- The U.S. Defense Department's Medical Supply Chain awarded a $27.2K firm fixed-price delivery order to Cepheid Inc. for the KIT XPERT XPRESS COVID-19, Influenza, and RSV molecular diagnostic kit on July 23, 2025, with completion targeted for July 25, 2025. The contract, which carries no set-aside designation, will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of Cepheid's established role as a primary supplier of molecular...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The Defense Logistics Agency awarded a $2,992 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract 4568960202 for COVID-19, influenza, and respiratory syncytial virus (RSV) testing supplies and services. This firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by August 15, 2025, and represents procurement of diagnostic reagents and related testing materials from Cepheid's GeneXpert...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8AX2Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on July 22, 2025, for the XpertXpress COVID-19, Influenza, RSV, and Molecular Biology test kit. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will perform the work at its California facility. This delivery order carries no set-aside designation and represents a continuation of Cepheid's long-standing relationship supplying diagnostic testing solutions to federal healthcare systems, particularly the Department of Veterans Affairs and Defense Health Agency. This award reflects Cepheid's established expertise in providing rapid molecular diagnostic testing capabilities for infectious diseases across multiple federal agencies. The company operates under two significant IDV contracts with VA Veterans Integrated Service Networks valued at approximately $35.3M combined, which facilitate ongoing procurement of molecular diagnostic systems, reagents, and assays through 2030. The current delivery order aligns with the Defense Department's broader healthcare logistics objectives and Cepheid's core business of delivering diagnostic equipment and testing services for detecting respiratory and infectious diseases within federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 7/22/25 |